安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Tetrabenazine: Uses, Dosage, Side Effects, Interactions more - Drugs. com
Tetrabenazine tablets are used to treat involuntary movements (chorea) caused by Huntington's disease, which is a rare, inherited disease that causes nerve cells in the brain to breakdown and die
- Tetrabenazine - Wikipedia
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders It is sold under the brand names Nitoman and Xenazine among others On August 15, 2008, the US Food and Drug Administration (FDA) approved the use of tetrabenazine to treat chorea associated with Huntington's disease
- Tetrabenazine (Xenazine): Uses, Side Effects, Dosage Reviews - GoodRx
Tetrabenazine (Xenazine) is a vesicular monoamine transporter 2 (VMAT2) inhibitor It's not exactly known how tetrabenazine (Xenazine) helps with chorea from Huntington's disease, but it's thought to block the VMAT2 protein in your brain
- Tetrabenazine (oral route) - Mayo Clinic
Tetrabenazine is used to treat chorea (a movement disorder) that is caused by Huntington disease Tetrabenazine works in the central nervous system (CNS) to prevent the absorption of certain chemicals (such as dopamine and serotonin)
- Tetrabenazine (Xenazine) - Uses, Side Effects, and More
Overview: Tetrabenazine is a medicine used to treat chorea caused by Huntington’s disease The medicine works to block certain chemicals in the brain, which helps cause less
- Tetrabenazine Tablets: Uses Side Effects - Cleveland Clinic
Tetrabenazine is a medication that treats involuntary movements caused by Huntington’s disease This condition attacks your brain, causing unsteady and uncontrollable movements (chorea) in your hands, feet and face
- Tetrabenazine: MedlinePlus Drug Information
Tetrabenazine is used to treat chorea (sudden movements that you cannot control) caused by Huntington's disease (an inherited disease that causes the progressive breakdown of nerve cells in the brain)
- tetrabenazine (Rx) - Medscape Drugs Diseases
Indicated for treatment of chorea associated with Huntington’s disease Individualize and slowly titrate dosage over several weeks to identify a dose that reduces chorea and is
|
|
|